| INTRODUCTION
Injection drug use is one of the major public health problems in Iran. 1 According to a Harm Reduction International report in 2013, there are estimated to be 170 000 to 230 000 PWID in Iran. [2] [3] [4] [5] It has been demonstrated that injection drug use is associated with numerous adverse health outcomes, such as blood-borne infections (HIV, HCV) and injection site skin infections (abscesses, cellulites). [6] [7] [8] Many studies have shown that skin and soft tissue abscesses are a common and costly complication of injection drug use. 9 Among PWID, frequent recurrence of skin infections results in numerous complications, including scarring and deformity. 10 The prevalence of skin infections has shown a positive association with frequency of injections. 9 Several studies have reported additional factors associated with skin infections, such as history of incarceration, polydrug use, and some injection-related risk behaviors. 11, 12 More frequent injections and use of contaminated water sources are also associated with skin and soft tissue abscesses among PWID. 13 Finally, a study in Denver, US showed heroin injecting and polydrug injecting may heighten the risk of skin and soft tissue abscesses in PWID. 14 Little is known about the prevalence of injection site skin infections among PWID in developing countries, including Iran. We hypothesized that risky injection practices such reuse of one's own syringes, frequent injection, and amphetamine injecting would be associated with skin infections among PWID. The aim of this study was to determine prevalence of injection site skin infections and its associated factors among PWID in Tehran, Iran.
| ME TH ODOLOGY
This cross-sectional study was conducted from June to July 2016 in Tehran. PWID were recruited by convenience and snowball sampling (ie, using peers to refer participants to the study) from five of DIC located at south of Tehran. Inclusion criteria were age 18 years or more, using drugs through injection least once during last month, and ability to provide informed consent to complete the interview. 
| RESULTS
The analytical sample comprised 500 participants (100% male). The Overall, 40% (CI95%: 36.3%, 44.2%) of participants reported ever having an injection site infection. Table 1 presents skin infections by socio-demographic and behavioral characteristics. Participants with skin infections were more likely to be unemployed (53% vs 48%, P = .02), be homeless (75% vs %35, P = .02), be of low socioeconomic status (70% vs 65%, P = .03), inject methamphetamine (44% vs 65%, P = .04), started drug use under the age of 22 years (56% vs 50%, P = .01), share syringes (22% vs 33%, P = .03), and engage in polydrug use (42% vs 55%, P = .01). Table 2 describes the bivariate and multivariate logistic analyses of variables associated with lifetime history of injection site skin infections among PWID. As illustrated in Table 2 , in bivariate analysis, having skin infections was associated with age of drug use initiation (OR = 1.6, P = .01), methamphetamine injection (OR = 2.1, P = .04), history of sexually transmitted infections (OR = 1.7, P = .02), reuse of one's own syringes (OR = 6.3, P = .03), injecting more than once per day (OR = 3.4, P = .03), and positive HIV status (OR = 2.7, P = .01). After adjusting for covariates (Table 2) 
| DISCUSSION
To our knowledge, this is the first study conducted on injection site infections and its associated risk factors among PWID in Iran. Our findings suggest that PWID who engage in certain injection-related behaviors are more likely to report skin infections. There was a significant association between number of injection per day, sharing syringes, lack of utilization of NSP services, low socioeconomic status, and reuse of one's own syringes with skin infections in PWID.
Our data showed that the prevalence of lifetime injection sites skin infections among PWID was 40%. The high prevalence of selfreported injection site skin infections found in this study was similar to that reported in other international studies. A study in San Francisco found that 38% of PWID in San Francisco had a history of lifetime injection site skin abscesses, cellulitis, or both. 14 A national survey in England reported that 36% of PWID have had an injection site skin infection during last year. 16 Our results revealed that there is a significant association between low socioeconomic status and skin infections, so that the odds of skin infection in low socioeconomic status PWID were 2.4 times more than others. Many people who are homeless have access to low social support and suffer from many co-occurring health problems, including both communicable and noncommunicable diseases. 17 As such, providing health education and prevention programs for PWID of low socioeconomic status is needed. Moreover, our findings showed that the number of (78) injections per day was a primary risk factor for skin infection. This is in line with previous international studies which have shown PWID who inject more frequently are less likely to practice skin cleaning and are at higher risk for skin infections. 9 This may be explained by demands associated with frequent injections or fatalism about benefits of skin cleaning. 10 We found a significant associations between the reuse of one's own syringes with injection sites skin infections, which is consistent with the results of a study from San Francisco, US. 9 Although reusing one's own syringes does not contribute to transmitting blood-borne diseases per se, it could greatly contribute to injection site skin infections. 18 Our finding is similar to previous studies that indicated that HIV status was associated with skin abscess. In our study, the adjusted odds ratio for HIV infection was similar to the adjusted rate ratio that was reported in a previously published article of a cohort study. 19 Multivariable analysis showed that there is a negative significant association between utilization of NSP services with skin infection.
Increasing access to NSPs will likely decrease rates of skin infection among PWID. There are data which demonstrate that greater utilization of needle exchange is associated with decreased abscess rates among PWID in Eureka, California. 13 This suggests that increasing the number of distributed syringes/needles by scaling up secondary distribution, expanding the coverage (hours and venues) of NSP services, and establishing NSP services within high-risk neighborhoods where PWID might be effective at reducing unsafe injection rates and skin infection among PWID. Policy makers should investigate approaches to promote safe injection site management in order to minimize vascular damage, reduce problems with peripheral venous access, among PWID.
Limitations to our study must also be noted. These include the cross-sectional nature of the study design, which does not enable us to directly investigate the causal relationships between independent variables and skin infection. Also, the sample is not a random sample, and caution is thereby necessary in generalizing the results to all PWID living in Iran. Furthermore, our data were based on participant self-report and therefore this may be subject to recall and social desirability bias.
| CONCLUSION
Injection site infections are highly prevalent among PWID in Tehran.
We have identified several risk factors for injection site skin infections among PWID, including number of injection per day, sharing syringes, not using NSP services, HIV status, and socioeconomic status. There is an urgent need to implement prevention and treatment programs for injection site skin infections among PWID in Iran.
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